Xiao-Lei Chen

14PUBLICATIONS
73CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 26, 2025
Ovarian Tumor FAK Inhibition Releases Omega-3 Fatty Acids Stimulating GATA6 Peritoneal Macrophage CXCL13 Production Enhancing Immunotherapy.

Xiao Lei Chen, Kevin M Tharp, Marjaana Ojalill

|Sep 13, 2025
Liposomal Doxorubicin, but Not Platinum-Taxane, Supports MHC-II Expression and Immune Maturation in the Ovarian Tumor Microenvironment.

Hyojae Lee, Xiao-Lei Chen, Duygu Ozmadenci

|Nov 25, 2024
Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma.

Yichi Zhang, Marjaana Ojalill, Antonia Boyer

|Nov 22, 2024
Inducible FAK Deletion but not FAK Inhibition in Endothelial Cells Activates p53 to Suppress Tumor Growth in PYK2-null Mice.

Xiao Lei Chen, Marjaana Ojalill, Christine Jean

|Apr 24, 2023
TMEM25 inhibits monomeric EGFR-mediated STAT3 activation in basal state to suppress triple-negative breast cancer progression.

Jing Bi, Zhihui Wu, Xin Zhang

|Mar 28, 2023
Themis suppresses the effector function of CD8+ T cells in acute viral infection.

Jian Tang, Xian Jia, Jian Li

Pageof 3

Frequent Collaborators

7 joint publications

Guo Fu

5 joint publications

Dwayne Stupack

5 joint publications

David D Schlaepfer

4 joint publications

Marjaana Ojalill